ACAD

ACADIA Pharmaceuticals Inc.

Price

$30.21

return (12m)

20.99%

p/e

12.76

p/bv

3.71

DIVIDEND YIELD

0.00%

ACAD price

ACADIA Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ACAD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

20.12%

3 months

41.70%

1 year

20.99%

2 years

91.69%

5 years

81.12%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ACAD

Valuation

P/E

12.76

Sector -4.38

Industry -4.38

P/BV

3.71

Sector 2.02

Industry 2.02

P/Revenue (PSR)

4.26

Sector -4.40

Industry -4.40

EV/EBITDA

95.08

Sector -263.09

Industry -263.09

EV/EBIT

103.00

Sector -702.90

Industry -702.90

P/EBITDA

49.33

Sector -4.39

Industry -4.39

P/EBIT

56.20

Sector -4.73

Industry -4.73

P/Total Assets

2.78

Sector 1.49

Industry 1.49

P/Net Current Assets

6.16

Sector -11.70

Industry -11.70

P/Working Capital

5.62

Sector -3.19

Industry -3.19

EPS

2.21

Sector -2.14

Industry -2.14

BVPS

7.60

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

91.13%

Sector 36.74%

Industry 36.74%

EBITDA Margin

13.31%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

12.29%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

7.59%

Sector -38.22%

Industry -38.22%

Net Profit Margins

33.42%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.18

Sector 0.03

Industry 0.03

Profitability

ROE

29.12%

Sector -65.14%

Industry -65.14%

ROA

21.83%

Sector -65.53%

Industry -65.53%

ROIC

18.31%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

3.39

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-23.33

Sector -6.07

Industry -6.07

Net Debt / EBIT

-25.28

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.73

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.75

Sector 0.41

Industry 0.41

Liabilities/Assets

0.25

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

18.65%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF ACADIA Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$30.21

Fair Value

$19.44

Upside Return potential.

-35.65%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ACAD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ACAD ACADIA Pharmaceuticals Inc.	$30.21	20.99%	0.00%	12.76	3.71	29.12%	33.42%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ACAD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ACADIA Pharmaceuticals

ACADIA Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (3 people)

United States

33 years

Founded: 1993

2004

Time since IPO - 22 years

601

Employees

ACADIA Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.85 billion, with shareholders equity totaling $1.31 billion.

The company employs approximately 601 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, ACADIA Pharmaceuticals Inc. reported $1.14 billion in revenue, generating net income of $380.49 million.

Key financial metrics include a P/E ratio of 12.76, a price-to-book (P/B) ratio of 3.71, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ACAD.

Market cap

$4.85 billion

Net worth

$1.31 billion

$1,306,610,000.00

Assets

$1.74 billion

$1,742,900,000.00

Total Shares Outstanding

172.00 million

172,000,000

Average Daily Trading Volume

$1.68 million

$1,679,206.00

Sector

Health Care

Industry

Biotechnology

ACAD

ACAD revenue and profits

Financial Results ACAD

DRAG THE FRAME TO SEE MORE DATA

ACAD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of ACADIA Pharmaceuticals (ACAD) today?

A cotação de ACADIA Pharmaceuticals (ACAD) hoje está em US$ 30.21, com uma variação de 20.99% em relação ao último ano. A cotação de ACADIA Pharmaceuticals (ACAD) iniciou o ano negociando na casa dos US$ 26.71 e hoje está em US$ 30.21. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de ACADIA Pharmaceuticals (ACAD) e dados de ações do Ibovespa e mercados internacionais.

Quando ACADIA Pharmaceuticals (ACAD) paga dividendos?

ACADIA Pharmaceuticals (ACAD) não distribuiu dividendos no último ano.

Is ACADIA Pharmaceuticals (ACAD) a good investment?

Atualmente, ACADIA Pharmaceuticals (ACAD) está cotada a US$ 30.21, com um P/L de 12.76, representando um desvio de -1,191% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 20.99 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 20.99%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy ACADIA Pharmaceuticals (ACAD) stock?

Investir em ações de ACADIA Pharmaceuticals (ACAD) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of ACADIA Pharmaceuticals (ACAD) yield today?

A rentabilidade de ACADIA Pharmaceuticals (ACAD) foi de 20.12% no último mês, 20.99% no último ano e 81.12% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de ACADIA Pharmaceuticals (ACAD) hoje, o investimento total seria de US$ 3,021.00, com base na cotação atual de US$ 30.21.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 3,655.11
Em 5 anos: US$ 5,471.64
Em 10 anos: US$ 3,021.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ACAD

ACADIA Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ACAD

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING ACAD WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT ACADIA Pharmaceuticals

ACADIA Pharmaceuticals Inc.

United States

33 years

2004

601

PROFIT X PRICE ACAD

Financial Results ACAD

ACAD cash flow

Asset, Revenue and Profit Growth - ACAD

ACAD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions